Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count

Lenalidomide is efficient in reducing red blood cell transfusion dependency and markedly lowering platelet counts in MDS/MPN‐RS‐T in the context of major platelet counts.

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Case Rep
Main Authors: Divoux, Marion, Plocque, Alexia, Sevin, Margaux, Voillat, Laurent, Feugier, Pierre, Guerci‐Bresler, Agnès, Girodon, Francois, Broséus, Julien
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7495870/
https://ncbi.nlm.nih.gov/pubmed/32983494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados